Trials / Completed
CompletedNCT07458828
Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair Health
Oral Hydrolyzed Keratin Peptide Powder Improves Hair Quality and Scalp Barrier Function: A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Dong-A Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to evaluate the efficacy and safety of Hydrolyzed Keratin Peptide Powder in promoting hair health in adult with mild to moderate hair damage, compared to a placebo control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | DAP-HAI-403 | Each subject takes two capsules per day for 24 weeks. Each capsule contains DAP-HAI-403 250mg. |
| DIETARY_SUPPLEMENT | Placebo | Each subject takes two capsules per day for 24 weeks. |
Timeline
- Start date
- 2024-01-23
- Primary completion
- 2025-01-21
- Completion
- 2025-08-12
- First posted
- 2026-03-09
- Last updated
- 2026-03-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07458828. Inclusion in this directory is not an endorsement.